Joseph Catanzaro's
Stock Forecasts
16.67%
6/36 win trades
Price targets by Joseph Catanzaro
Company name & ticker | Publish date | Price target | Price when posted | Source | Historical targets |
---|---|---|---|---|---|
![]() Halozyme Therapeutics, Inc. HALO | 10 months ago | $52 -25.71% downside | $46.72 | StreetInsider | |
![]() CytomX Therapeutics, Inc. CTMX | 10 months ago | $3.25 62.49% upside | $1.09 | StreetInsider | |
![]() Revolution Medicines, Inc. RVMD | 10 months ago | $70 91.57% upside | $56.09 | StreetInsider | |
![]() Gilead Sciences, Inc. GILD | 10 months ago | $105 -10.71% downside | $90.09 | StreetInsider | |
![]() ESSA Pharma Inc. EPIX | 10 months ago | $2 4.71% upside | $1.63 | StreetInsider | Previous targets (0) |
![]() Biomea Fusion, Inc. BMEA | 10 months ago | $19 1007.87% upside | $10.34 | TheFly | |
![]() Exelixis, Inc. EXEL | 10 months ago | $36 -4.10% downside | $28.73 | TheFly | Previous targets (0) |
![]() Iovance Biotherapeutics, Inc. IOVA | about 1 year ago | $10 283.14% upside | $9.25 | StreetInsider | |
![]() Keros Therapeutics, Inc. KROS | about 1 year ago | $105 624.13% upside | $44.65 | StreetInsider | Previous targets (0) |
![]() Context Therapeutics Inc. CNTX | over 1 year ago | $4.5 412.99% upside | $1.69 | StreetInsider | Previous targets (0) |
![]() Acrivon Therapeutics, Inc. Common Stock ACRV | over 1 year ago | $30 2139.47% upside | $9.2 | StreetInsider | Previous targets (0) |
![]() Achilles Therapeutics plc ACHL | over 1 year ago | $2 35.13% upside | $0.9 | TheFly | Previous targets (0) |
Other analysts covering same stocks
Tessa Romero
J.P. Morgan
100%
win rate
Covering:
Steve Chesney
Atlantic Equities
60%
win rate
Evan Seigerman
Loop Capital Markets
50%
win rate
Nick Abbott
Wells Fargo
50%
win rate